NorthWest Biotherapeutics Inc (NWBO)

[learningcurve2020]

>>Despite advances in medicine, charities warn that treatment choices for brain tumours - the biggest cancer killer of children and under-40s - remain severely restricted. Access to cutting-edge immunotherapies, specialist drug trials and clinical studies is scarce for British patients, leaving many to fund their own care.


That's exactly what Matt did after supporters raised funds enabling him to receive DcVax-L, a bespoke vaccine not offered through the NHS but obtainable privately in Britain for £100,000. He said: "I was only able to have the DcVax-L because of the random kindness of strangers.

"Without them I'd never have raised the £100,000 needed. But I was only able to have four doses because my tumour tissue had been stored incorrectly. Proper tissue storage can change lives, people need to understand how important it is."

>> Matt added: "It is deeply frustrating to see treatment options available elsewhere in Europe and the USA that aren't accessible here on the NHS. Even in France, people are reimbursed by the government if they pay privately for treatment abroad. Why isn't the UK doing the same? The NHS needs to be brought up to speed, more needs to be done."

https://www.mirror.co.uk/news/health/mans-warning-pins-needles-leads-36516209